A high-throughput cellular assay to quantify the p53- degradation activity of E6 from different human papillomavirus types

Methods in Molecular Biology

Volumn 1249, Issue , 2015, Pages 111-120

  Gagnon, David ^a   Archambault, Jacques ^a  

^a NONE

Author keywords

Cancer; Cell based assay; E6; High risk; High throughput; Low risk; Luciferase; Oncogenesis; P53; Papillomavirus

Indexed keywords

FIREFLY LUCIFERASE; HYBRID PROTEIN; PROTEASOME; PROTEIN E6; PROTEIN P53; RENILLA LUCIFERIN 2 MONOOXYGENASE; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; LUCIFERASE; ONCOPROTEIN; REPRESSOR PROTEIN;

ARTICLE; CELL ASSAY; CELL FUSION; CONCENTRATION RESPONSE; EC50; ENZYME ACTIVITY; EXPRESSION VECTOR; GENETIC TRANSFECTION; HIGH THROUGHPUT CELLULAR ASSAY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; INFECTION RISK; LUCIFERASE ASSAY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; QUANTITATIVE ASSAY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; STEADY STATE; UTERINE CERVIX CARCINOMA; WART VIRUS; GENE VECTOR; HIGH THROUGHPUT SCREENING; METABOLISM; PLASMID; PROCEDURES; TUMOR CELL LINE;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRIDAE; RENILLA LUCIFERASE;

CELL LINE, TUMOR; GENETIC VECTORS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LUCIFERASES; ONCOGENE PROTEINS, VIRAL; PLASMIDS; PROTEOLYSIS; REPRESSOR PROTEINS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84958608703     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2013-6_8     Document Type: Article

References (10)

1. Fu L, Van Doorslaer K, Chen Z, Ristriani T, Masson M, Trave G, Burk RD (2010) Degradation of p53 by human alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity. PloS One. 5
2. Lehoux M, D’Abramo CM, Archambault J (2009) Molecular mechanisms of human papillomavirus- induced carcinogenesis. Public Health Genomics 12:268–280
3. Camus S, Menendez S, Cheok CF, Stevenson LF, Lain S, Lane DP (2007) Ubiquitinindependent degradation of p53 mediated by high-risk human papillomavirus protein E6. Oncogene 26:4059–4070
4. Huibregtse JM, Scheffner M, Howley PM (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10: 4129–4135
5. Massimi P, Shai A, Lambert P, Banks L (2008) HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background. Oncogene 27:1800–1804
6. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitinprotein ligase in the ubiquitination of p 53. Cell 75:495–505
7. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p 53. Cell 63:1129–1136
8. Thomas M, Banks L (2005) In vitro assays of substrate degradation induced by high-risk HPV E6 oncoproteins. Methods Mol Med 119:411–417
9. Mesplede T, Gagnon D, Bergeron-Labrecque F, Azar I, Senechal H, Coutlee F, Archambault J (2012) p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes. J Virol 86:94–107
10. Gagnon D, Joubert S, Senechal H, Fradet- Turcotte A, Torre S, Archambault J (2009) Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4. J Virol 83:4127–4139